Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Zignol

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Expert Review of Anti-Infective Therapy|May 3, 2018
Use of whole genome sequencing in surveillance of drug resistant tuberculosisRuth McNerney, Matteo Zignol, Taane G Clark
Advances in Experimental Medicine and Biology|November 9, 2017
Epidemiology of Drug-Resistant TuberculosisAnna S Dean, Helen Cox, Matteo Zignol
Plos One|August 11, 2011
Quantifying the burden and trends of isoniazid resistant tuberculosis, 1994-2009Helen E Jenkins, Matteo Zignol, Ted Cohen
Frontiers in Immunology|October 5, 2023
The impact of the COVID-19 pandemic on the global tuberculosis epidemicDennis Falzon, Matteo Zignol, Mathieu Bastard, et al.
Ethiopian Medical Journal|March 11, 2008
Tb drug resistance: is it really a threat to Africa?Paul Nunn, Matteo Zignol, Ernesto Jaramillo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2006
Patients with previously treated tuberculosis no longer neglectedMatteo Zignol, Abigail Wright, Ernesto Jaramillo, et al.
American Journal of Respiratory and Critical Care Medicine|March 29, 2008
Challenges in estimating the total burden of drug-resistant tuberculosisTed Cohen, Caroline Colijn, Abigail Wright, et al.
The European Respiratory Journal|December 11, 2012
Multidrug-resistant tuberculosis in children: evidence from global surveillanceMatteo Zignol, Charalambos Sismanidis, Dennis Falzon, et al.
Tropical Medicine & International Health : TM & IH|May 7, 2015
National tuberculosis prevalence surveys in Asia, 1990-2012: an overview of results and lessons learnedIkushi Onozaki, Irwin Law, Charalambos Sismanidis, et al.
Health and Human Rights|September 18, 2010
Limitations on human rights: are they justifiable to reduce the burden of TB in the era of MDR- and XDR-TB?Andrea Boggio, Matteo Zignol, Ernesto Jaramillo, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Expert Review of Anti-Infective Therapy|May 3, 2018
Use of whole genome sequencing in surveillance of drug resistant tuberculosisRuth McNerney, Matteo Zignol, Taane G Clark
Advances in Experimental Medicine and Biology|November 9, 2017
Epidemiology of Drug-Resistant TuberculosisAnna S Dean, Helen Cox, Matteo Zignol
Plos One|August 11, 2011
Quantifying the burden and trends of isoniazid resistant tuberculosis, 1994-2009Helen E Jenkins, Matteo Zignol, Ted Cohen
Frontiers in Immunology|October 5, 2023
The impact of the COVID-19 pandemic on the global tuberculosis epidemicDennis Falzon, Matteo Zignol, Mathieu Bastard, et al.
Ethiopian Medical Journal|March 11, 2008
Tb drug resistance: is it really a threat to Africa?Paul Nunn, Matteo Zignol, Ernesto Jaramillo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2006
Patients with previously treated tuberculosis no longer neglectedMatteo Zignol, Abigail Wright, Ernesto Jaramillo, et al.
American Journal of Respiratory and Critical Care Medicine|March 29, 2008
Challenges in estimating the total burden of drug-resistant tuberculosisTed Cohen, Caroline Colijn, Abigail Wright, et al.
The European Respiratory Journal|December 11, 2012
Multidrug-resistant tuberculosis in children: evidence from global surveillanceMatteo Zignol, Charalambos Sismanidis, Dennis Falzon, et al.
Tropical Medicine & International Health : TM & IH|May 7, 2015
National tuberculosis prevalence surveys in Asia, 1990-2012: an overview of results and lessons learnedIkushi Onozaki, Irwin Law, Charalambos Sismanidis, et al.
Health and Human Rights|September 18, 2010
Limitations on human rights: are they justifiable to reduce the burden of TB in the era of MDR- and XDR-TB?Andrea Boggio, Matteo Zignol, Ernesto Jaramillo, et al.
Pageof 9